BullishAgent BullishAgent Filings Market Earnings Ratings ETFs Insiders Shorts
Screener
Sign in Register
Ratings · Intelligence · HC Wainwright & Co.

HC Wainwright & Co.

8,414 total ratings · Since 2013 · View all ratings →
Upgrade grade
B
Downgrade grade
C
HC Wainwright & Co. was founded in 1988 and has evolved into a diversified investment bank headquartered in New York with a strong presence across equity research, institutional sales, and corporate advisory services. The firm has established itself as a meaningful player in small and mid-cap equity coverage, with approximately 8,414 analyst ratings calls in our database, reflecting substantial depth in tracking US equities across multiple sectors. HC Wainwright has built particular expertise and recognition in healthcare, life sciences, and technology sectors, where they maintain dedicated analyst teams that follow both established companies and emerging growth opportunities. The firm has developed a distinctive reputation for its contrarian research perspectives and willingness to take independent positions on controversial or overlooked companies, earning respect from institutional investors who value their detailed fundamental analysis and sector expertise despite the firm's lower mainstream profile compared to larger bulge-bracket competitors.
Upgrades
95
74.74% win rate · avg +6.56% D1
Downgrades
140
70.71% win rate · avg -11.21% D1
Avg Gap — Upgrades
+6.93%
open vs prev close
Avg Gap — Downgrades
-9.74%
open vs prev close

Performance by Sector

Sector ↑ Win% ↑ D1 ↓ Win% ↓ D1
Healthcare 76.12% (67) +7.65% 75.68% (111) -13.96%

Win Rate by Year

Year ↑ Win% ↑ Calls ↓ Win% ↓ Calls
2026 46.2% 13
2025 73.3% 30 72.7% 33
2024 81.0% 21
2023 58.3% 12 85.7% 14
2022 70.6% 17
2021 82.4% 17 61.5% 13
2020 64.3% 14

Recent Calls

Date Ticker Company Sector Action Grade Change PT Gap D1
Apr 30, 2026 IONS Ionis Pharmaceuticals, Inc. Healthcare Maintains Buy Buy +0.1% -0.1%
Apr 30, 2026 GMAB Genmab A/S Healthcare Maintains Buy Buy +1.3% +1.6%
Apr 29, 2026 AXGN AxoGen, Inc. Healthcare Maintains Buy Buy -1.1% -0.5%
Apr 29, 2026 RLAY Relay Therapeutics, Inc. Healthcare Maintains Buy Buy +1.1% -3.5%
Apr 29, 2026 BBIO BridgeBio Pharma, Inc. Healthcare Maintains Buy Buy -2.0% +1.8%
Apr 28, 2026 GROY Gold Royalty Corp. Basic Materials Maintains Buy Buy -2.8% -3.1%
Apr 28, 2026 CGEM Cullinan Therapeutics, Inc. Healthcare Maintains Buy Buy +1.1% -3.3%
Apr 28, 2026 CMPS COMPASS Pathways plc Healthcare Maintains Buy Buy -1.6% -5.1%
Apr 27, 2026 DWTX Dogwood Therapeutics, Inc. Healthcare Maintains Buy Buy -2.2% -2.9%
Apr 27, 2026 NRXP NRx Pharmaceuticals, Inc. Healthcare Maintains Buy Buy +1.7% +3.1%
Apr 27, 2026 ENTX Entera Bio Ltd. Healthcare Maintains Buy Buy +2.7% +2.7%
Apr 27, 2026 ACOG Alpha Cognition Inc. Common Stock Financial Services Maintains Buy Buy -1.6% -6.3%
Apr 27, 2026 CMPX Compass Therapeutics, Inc. Healthcare Maintains Buy Buy -64.8% -64.4%
Apr 27, 2026 PRLD Prelude Therapeutics Incorporated Healthcare Maintains Buy Buy +4.7% -3.8%
Apr 27, 2026 ITRG Integra Resources Corp. Basic Materials Maintains Buy Buy +0.0% -2.7%
Apr 27, 2026 URG Ur-Energy Inc. Energy Maintains Buy Buy -0.6% +4.1%
Apr 27, 2026 JBIO Jade Biosciences, Inc. Healthcare Maintains Buy Buy +3.2% +7.5%
Apr 27, 2026 NRIX Nurix Therapeutics, Inc. Healthcare Maintains Buy Buy -1.0% -1.1%
Apr 27, 2026 MIRM Mirum Pharmaceuticals, Inc. Healthcare Maintains Buy Buy +0.6% +1.1%
Apr 27, 2026 BBIO BridgeBio Pharma, Inc. Healthcare Maintains Buy Buy +3.5% +1.7%
Apr 27, 2026 BNTX BioNTech SE Healthcare Maintains Buy Buy +0.1% -3.2%
Apr 24, 2026 EVAX Evaxion Biotech A/S Healthcare Maintains Buy Buy +0.5% -5.2%
Apr 24, 2026 GUTS Fractyl Health, Inc. Common Stock Healthcare Maintains Buy Buy +1.5% +6.7%
Apr 23, 2026 CRVO CervoMed Inc. Healthcare Maintains Buy Buy +0.5% -2.3%
Apr 23, 2026 KYTX Kyverna Therapeutics, Inc. Healthcare Maintains Buy Buy -0.6% -12.5%